76
Participants
Start Date
July 2, 2014
Primary Completion Date
August 31, 2016
Study Completion Date
November 30, 2016
Isotretinoin
Isotretinoin is a drug that is approved for use in the treatment of severe acne. The aim of this study is to evaluate the role of Isotretinoin on immune activation and inflammation.
31787 University of Rochester Adult HIV Therapeutic Strategies Network CRS, Rochester
3203 Greensboro CRS, Greensboro
3201 Chapel Hill CRS, Chapel Hill
31788 Alabama CRS, Birmingham
3652 Vanderbilt Therapeutics (VT) CRS, Nashville
2101 Washington University Therapeutics (WT) CRS, St Louis
31473 Houston AIDS Research Team (HART) CRS, Houston
601 University of California, Los Angeles CARE Center CRS, Los Angeles
801 University of California, San Francisco HIV/AIDS CRS, San Francisco
101 Massachusetts General Hospital (MGH) CRS, Boston
107 Brigham and Women's Hosp. ACTG CRS, Boston
31786 New Jersey Medical School Clinical Research Center CRS, Newark
2401 Cincinnati CRS, Cincinnati
2951 The Miriam Hospital (TMH) ACTG CRS, Providence
5401 Puerto Rico AIDS Clinical Trials Unit CRS, San Juan
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
NETWORK